Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Despite scoring an FDA nod, Merck's biosim Lusduna must wait to challenge Lantus
Fierce Pharma
Sun, 07/23/17 - 11:40 am
Tags:
FDA, Merck, biosimilars, Lusduna Nexvue, Lantus, diabetes, Sanofi, Hatch Waxman Act
Sanofi offers Ablynx billions of biobucks for nanobody partnership
Fierce Biotech
Thu, 07/20/17 - 11:26 am
Tags:
Sanofi, Ablynx, nanobodies, R&D
With help from Novartis and Sanofi, NeuroVia heads to the clinic armed with a $14M round
Endpoints
Thu, 07/20/17 - 10:47 am
Tags:
Novartis, Sanofi, NeuroVia, X-ALD
The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.
Fierce Pharma
Wed, 07/19/17 - 10:22 am
Tags:
GSK, Sanofi, vaccines, flu vaccines, Seqirus
Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent
Fierce Pharma
Sun, 07/16/17 - 02:53 pm
Tags:
payers, Sanofi, Regeneron, eczema, Dupixent, dupilumab
Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy
Fierce Pharma
Tue, 07/11/17 - 11:15 am
Tags:
Sanofi, Sanofi Pasteur, M&A, Protein Sciences, flu vaccine, vaccines
Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses
Bloomberg
Sat, 07/8/17 - 10:18 am
Tags:
patents, Roche, Sanofi, Eli Lilly, patent cliff
Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul
Bloomberg
Fri, 07/7/17 - 10:31 am
Tags:
rare disease, healthcare reform, Shire, Jazz Pharmaceuticals, Sanofi, Roche, Biogen, Alexion, Vertex Pharmaceuticals
Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug
Endpoints
Fri, 07/7/17 - 10:22 am
Tags:
Sanofi, Alnylam, clinical trials, fitusiran, hemophilia, Roche, emicizumab
EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts
Fierce Biotech
Thu, 07/6/17 - 05:58 pm
Tags:
Europe, biotech, Brexit, BioNTech, GSK, artificial intelligence, Sanofi, Exscientia, Silence Therapeutics, RNAi
Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication
Fierce Pharma
Thu, 07/6/17 - 02:40 pm
Tags:
Sanofi, Zika virus, vaccines, Department of Defense
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
Tags:
prescription data, Sanofi, Lantus, Roche, Herceptin, Avastin, Celgene, Revlimid, JNJ, Merck, Remicade, Biogen, Rituxan, Amgen, Enbrel, Gilead Sciences, Harvoni, AbbVie, Humira
Senators lay into Sanofi for Zika vaccine deal, call for public hearing
Fierce Pharma
Wed, 06/28/17 - 09:26 am
Tags:
vaccines, Senate, Zika virus, Sanofi, Sanofi Pasteur
Regeneron’s Praluent May See Gradual Increase in 2017 Demand
Market Realist
Tue, 06/20/17 - 09:31 am
Tags:
Regeneron, Praluent, Sanofi
Sanofi: A Good Bet On Pharma
Seeking Alpha
Sun, 06/18/17 - 11:59 pm
Tags:
Sanofi
Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact"
Reuters
Fri, 06/16/17 - 10:01 pm
Tags:
Sanofi, Supreme Court, biologics, Olivier Brandicourt
Sanofi, Parexel collaborate on clinical trial data collection wearables
Drug Delivery Business News
Thu, 06/15/17 - 02:34 pm
Tags:
Sanofi, Parexel, clinical trials, clinical trial data, wearables
Lexicon Pharma Goes Three For Three With Sotagliflozin Data
Seeking Alpha
Tue, 06/13/17 - 12:06 pm
Tags:
Lexicon Pharmaceuticals, sotagliflozin, type 1 diabetes, Sanofi
Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Fierce Pharma
Mon, 06/12/17 - 09:40 pm
Tags:
Sanofi, Gilead Sciences, Tesaro, M&A
Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics
Fierce Pharma
Mon, 06/12/17 - 09:42 am
Tags:
Sanofi, Regeneron, Praluent, diabetes, LDL cholesterol

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.